Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nat Struct Mol Biol. 2023 Oct;30(10):1495-1504. doi: 10.1038/s41594-023-01085-6. Epub 2023 Sep 7.
Anion exchanger 1 (AE1), a member of the solute carrier (SLC) family, is the primary bicarbonate transporter in erythrocytes, regulating pH levels and CO transport between lungs and tissues. Previous studies characterized its role in erythrocyte structure and provided insight into transport regulation. However, key questions remain regarding substrate binding and transport, mechanisms of drug inhibition and modulation by membrane components. Here we present seven cryo-EM structures in apo, bicarbonate-bound and inhibitor-bound states. These, combined with uptake and computational studies, reveal important molecular features of substrate recognition and transport, and illuminate sterol binding sites, to elucidate distinct inhibitory mechanisms of research chemicals and prescription drugs. We further probe the substrate binding site via structure-based ligand screening, identifying an AE1 inhibitor. Together, our findings provide insight into mechanisms of solute carrier transport and inhibition.
阴离子交换蛋白 1(AE1)是溶质载体(SLC)家族的成员,是红细胞中主要的碳酸氢盐转运蛋白,调节肺部和组织之间的 pH 值和 CO 运输。先前的研究描述了其在红细胞结构中的作用,并深入了解了运输调节。然而,关于底物结合和运输、药物抑制机制以及膜成分的调节机制等关键问题仍然存在。在这里,我们展示了七个在 apo、碳酸氢盐结合和抑制剂结合状态下的冷冻电镜结构。这些结构与摄取和计算研究相结合,揭示了底物识别和运输的重要分子特征,并阐明了固醇结合位点,以阐明研究化学品和处方药的不同抑制机制。我们进一步通过基于结构的配体筛选来探测底物结合位点,确定了一种 AE1 抑制剂。总之,我们的研究结果为溶质载体运输和抑制的机制提供了深入的了解。